Yi Lin

Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients

Songjian Chen, Xia Huo, Yi Lin et al. · International Journal of Hygiene and Environmental Health · 2010 · 68 citations

Cisplatin-based Chemotherapy, Medicine, Pathology +8

Anti-inflammatory effects of guggulsterone on murine macrophage by inhibiting LPS-induced inflammatory cytokines in NF-κB signaling pathway

Jinhua Zhang, Zhaoshui Shangguan, Chao Chen et al. · Drug Design Development and Therapy · 2016 · 32 citations · Full text

Inflammatory Lung Disease, Immunotoxicology, Lung Inflammation +22

Blood–brain barrier microfluidic chips and their applications

Mengmeng Li, Mingyang Zhu, Ruolan Huang et al. · Organs-on-a-Chip · 2023 · 20 citations · Full text

Engineering, Biomedical Engineering, Pharmacodynamic Modeling +22

OAB-027: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy, for the treatment of patients with relapsed and refractory multiple myeloma (RRMM): updated results from KarMMa

Larry Anderson, Nina Shah, Sundar Jagannath et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 14 citations

Hematological Malignancy, Oncology, Idecabtagene Vicleucel +5

Cytotoxic active ingredients from the seeds of Voacanga africana

Xuan Li, Yuan Deng, Lianchang Kang et al. · South African Journal of Botany · 2020 · 12 citations · Full text